Market Update Economic Events Directors Deals Commodities Prices News Market Movers

Mereo BioPharma bid for OncoMed Pharmaceuticals gains more support

Friday, 15th March 2019
Mereo BioPharma Group said its proposed acquisition of OncoMed Pharmaceuticals had now received backing from 21.1% of the target's shareholders.

OncoMed said it had received support for the deal from Biotechnology Value Fund, Biotechnology Value Fund II, MSI BVF SPV and Biotechnology Value Trading Fund OS L.P. which represented about 10.45% of OncoMed's shares.

The backing adds to support announced by other investors in December.

Mereo BioPharma said it continued to make good progress towards closing the deal, which expects to occur in the second quarter of 2019.

At 1:40pm: (LON:MPH) Mereo Biopharma Group Ltd share price was 0p at 167.5p

Story provided by

Related Shares: Mereo Bioph

Share Search
Share Search Share Search

Visit the Share Search.
Share Search

Share News
Share News will do their best to ensure the quality of the information displayed on this site, but all information is provided as-is, free of charge. We cannot be held responsible for any loss, material or otherwise, due to incorrect information found here. UK data supplied by NBTrader and Digital Look. Share Prices are at least 15 minutes delayed.